跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
mRNA: G
首页
药物
mRNA: G
mRNA: G
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
HSD17B13 VARIANTS AND USES THEREOF
EP 3571301 A1
申请人: REGENERON PHARMA
优先权: 2017
CN
EP
US
WO
10 件公开
Methods for the treatment of Leber congenital amaurosis
US 9012425 B2
申请人: ROZET JEAN-MICHEL
优先权: 2011
EP
US
8 件公开
IL-21 production in prokaryotic hosts
US 7250274 B2
申请人: ZYMOGENETICS INC
优先权: 2003
US
8 件公开
ENGINEERED NIPAH VIRUS MRNA VACCINE
EP 4661904 A2
申请人: VERNAGEN LLC
优先权: 2023
CN
EP
US
WO
4 件公开
DENDRITIC CELL-TARGETED VIROID DVLP, AND PREPARATION METHOD THEREFOR AND USE THEREOF
EP 4717766 A1
申请人: SHANGHAI BDGENE CO LTD
优先权: 2023
CN
EP
WO
4 件公开
Polynucleotides encoding SREB1 receptor
US 7341849 B2
申请人: ASTELLAS PHARMA INC
优先权: 1998
US
4 件公开
BASE EDITING APPROACHES FOR CORRECTING THE IVS2-1 (G>A) MUTATION IN PATIENTS SUFFERING FROM BETA-THALASSEMIA
EP 4558633 A1
申请人: INST NAT SANTE RECH MED
优先权: 2022
EP
US
WO
3 件公开
G protein coupled receptor protein and use thereof
US 9034327 B2
申请人: CHUNG KYUNG SOOK
优先权: 2009
CN
US
3 件公开
RNA OLIGONUCLEOTIDES FOR PREVENTING AGGREGATION OF PROTEINS
US 2022411794 A1
申请人: UNIV WIEN
优先权: 2019
EP
US
2 件公开
Synthetic peptide BRAP and application in preparation of anti-inflammatory drug for COVID-19 thereof
US 11401303 B2
申请人: TAIAN CITY QIHANG BIOTECHNOLOGY CO
优先权: 2020
CN
US
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈